Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155304812> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2155304812 abstract "Gastric cancer is the fourth most common malignancy worldwide with Japan, Korea, Taiwan, China, Mongolia and many countries in South America and eastern Europe, as well as parts of the Middle East, contributing to the majority of cases. In the USA, it was estimated that approximately 10,620 deaths would be caused by gastric cancer in 2010. Gastric cancer is often diagnosed in its advanced stages. Current first-line treatment for advanced gastric cancer (AGC) using triplet combination chemotherapy containing a platinum-based compound, a fluoropyrimidine with an anthracycline (frequently added in Europe) or a taxane (more often used in the USA and elsewhere) has resulted in higher response rates and modest improvement in overall survival compared with doublet combinations. However, triplet combinations can be associated with increased toxicity compared with the doublets and patient selection becomes important. A desirable research strategy is to improve outcomes of patients with AGC by identifying treatments that are effective, convenient and safe. The interest in oral agents compared with intravenous agents is mounting. One oral fluoropyrimidine, S-1, is novel as it combines tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate. S-1 is approved in Japan, China, Taiwan, Korea and Singapore for the treatment of patients with gastric cancer, and more recently has been approved in 27 European countries to treat AGC. Initial clinical trials in the USA and Europe observed diarrhea as the dose-limiting toxicity; however, initial Japanese studies reported myelosuppression as the dose-limiting toxicity. The differing dose tolerance in these two populations is likely due to polymorphisms in the CYP2A6 gene. Based on our review of Phase II and III studies, we conclude that S-1 is a convenient oral fluoropyrimidine that provides safety advantage over intravenous fluorouracil without compromising efficacy against AGC." @default.
- W2155304812 created "2016-06-24" @default.
- W2155304812 creator A5027873506 @default.
- W2155304812 creator A5039315780 @default.
- W2155304812 creator A5044064524 @default.
- W2155304812 date "2011-06-01" @default.
- W2155304812 modified "2023-09-25" @default.
- W2155304812 title "A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma" @default.
- W2155304812 cites W1974449546 @default.
- W2155304812 cites W1974957356 @default.
- W2155304812 cites W1980253503 @default.
- W2155304812 cites W1985233531 @default.
- W2155304812 cites W1994843088 @default.
- W2155304812 cites W2008575122 @default.
- W2155304812 cites W2018619890 @default.
- W2155304812 cites W2032540605 @default.
- W2155304812 cites W2035961702 @default.
- W2155304812 cites W2038926895 @default.
- W2155304812 cites W2039838462 @default.
- W2155304812 cites W2040872961 @default.
- W2155304812 cites W2053144686 @default.
- W2155304812 cites W2062004184 @default.
- W2155304812 cites W2065014168 @default.
- W2155304812 cites W2077902459 @default.
- W2155304812 cites W2092804614 @default.
- W2155304812 cites W2100439220 @default.
- W2155304812 cites W2100642935 @default.
- W2155304812 cites W2107890342 @default.
- W2155304812 cites W2112750298 @default.
- W2155304812 cites W2122866527 @default.
- W2155304812 cites W2128328462 @default.
- W2155304812 cites W2131972171 @default.
- W2155304812 cites W2133127344 @default.
- W2155304812 cites W2137991416 @default.
- W2155304812 cites W2138732660 @default.
- W2155304812 cites W2140410892 @default.
- W2155304812 cites W2152256906 @default.
- W2155304812 cites W2164411042 @default.
- W2155304812 cites W2168388707 @default.
- W2155304812 cites W2171075804 @default.
- W2155304812 cites W2171905219 @default.
- W2155304812 cites W2229238935 @default.
- W2155304812 cites W2396646859 @default.
- W2155304812 cites W2430807912 @default.
- W2155304812 cites W2528428498 @default.
- W2155304812 doi "https://doi.org/10.2217/fon.11.50" @default.
- W2155304812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21675835" @default.
- W2155304812 hasPublicationYear "2011" @default.
- W2155304812 type Work @default.
- W2155304812 sameAs 2155304812 @default.
- W2155304812 citedByCount "18" @default.
- W2155304812 countsByYear W21553048122012 @default.
- W2155304812 countsByYear W21553048122013 @default.
- W2155304812 countsByYear W21553048122014 @default.
- W2155304812 countsByYear W21553048122015 @default.
- W2155304812 countsByYear W21553048122016 @default.
- W2155304812 countsByYear W21553048122017 @default.
- W2155304812 countsByYear W21553048122018 @default.
- W2155304812 countsByYear W21553048122019 @default.
- W2155304812 countsByYear W21553048122020 @default.
- W2155304812 crossrefType "journal-article" @default.
- W2155304812 hasAuthorship W2155304812A5027873506 @default.
- W2155304812 hasAuthorship W2155304812A5039315780 @default.
- W2155304812 hasAuthorship W2155304812A5044064524 @default.
- W2155304812 hasConcept C121608353 @default.
- W2155304812 hasConcept C126322002 @default.
- W2155304812 hasConcept C143998085 @default.
- W2155304812 hasConcept C2776694085 @default.
- W2155304812 hasConcept C2776802502 @default.
- W2155304812 hasConcept C2777511904 @default.
- W2155304812 hasConcept C2779399171 @default.
- W2155304812 hasConcept C2781182431 @default.
- W2155304812 hasConcept C2993283237 @default.
- W2155304812 hasConcept C530470458 @default.
- W2155304812 hasConcept C71924100 @default.
- W2155304812 hasConceptScore W2155304812C121608353 @default.
- W2155304812 hasConceptScore W2155304812C126322002 @default.
- W2155304812 hasConceptScore W2155304812C143998085 @default.
- W2155304812 hasConceptScore W2155304812C2776694085 @default.
- W2155304812 hasConceptScore W2155304812C2776802502 @default.
- W2155304812 hasConceptScore W2155304812C2777511904 @default.
- W2155304812 hasConceptScore W2155304812C2779399171 @default.
- W2155304812 hasConceptScore W2155304812C2781182431 @default.
- W2155304812 hasConceptScore W2155304812C2993283237 @default.
- W2155304812 hasConceptScore W2155304812C530470458 @default.
- W2155304812 hasConceptScore W2155304812C71924100 @default.
- W2155304812 hasLocation W21553048121 @default.
- W2155304812 hasLocation W21553048122 @default.
- W2155304812 hasOpenAccess W2155304812 @default.
- W2155304812 hasPrimaryLocation W21553048121 @default.
- W2155304812 hasRelatedWork W2131972171 @default.
- W2155304812 isParatext "false" @default.
- W2155304812 isRetracted "false" @default.
- W2155304812 magId "2155304812" @default.
- W2155304812 workType "article" @default.